Organigram Global (OGI) Share-based Compensation (2018 - 2026)
Organigram Global (OGI) posted quarterly Share-based Compensation of $1.1 million for Q1 2026, up 67.1% year-on-year from $653707.7 in Q1 2025, and up 97.83% on a QoQ basis from $552156.4 in Q4 2025.
Organigram Global (OGI) Share-based Compensation (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Share-based Compensation for 7 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- Quarterly Share-based Compensation rose 67.1% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 46.96% YoY) and the FY2025 annual result came in at $3.1 million, down 41.8% from the prior year.
- Share-based Compensation grew to $1.1 million in Q1 2026 per OGI's latest filing, from $552156.4 in the prior quarter.
- Over the last five years, Share-based Compensation for OGI reached as high as $1.1 million in Q1 2026 and fell as low as $552156.4 in Q4 2025.
- A 3-year average of $811678.6 and a median of $801103.9 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2025 — Share-based Compensation plunged 41.79% — and 2026, when it jumped 67.1%.
- Year by year, Share-based Compensation stood at $948500.1 in 2024, then tumbled by 41.79% to $552156.4 in 2025, then surged by 97.83% to $1.1 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $1.1 million, $552156.4, and $653707.7 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 552,156.44 |
| Dec 31, 2025 | 552,156.44 |
| Mar 31, 2025 | 653,707.65 |
| Mar 31, 2025 | 653,707.65 |
| Dec 31, 2024 | 948,500.11 |
| Dec 31, 2024 | 948,500.11 |
| May 31, 2021 | 2.75 Mn |
| May 31, 2021 | 2.75 Mn |
| Feb 28, 2021 | 1.77 Mn |
| Feb 28, 2021 | 1.77 Mn |
| Nov 30, 2020 | 606,000.00 |
| Nov 30, 2020 | 606,000.00 |
| Aug 31, 2020 | 486,689.00 |
| Aug 31, 2020 | 486,689.00 |
| May 31, 2020 | 1.39 Mn |
| May 31, 2020 | 1.39 Mn |
| Feb 29, 2020 | 2.40 Mn |
| Feb 29, 2020 | 2.40 Mn |